• Mashup Score: 0

    CHARLOTTE, N.C. — Treatment for irritable bowel syndrome with diarrhea should target bloating in addition to diarrhea and abdominal pain or discomfort, according to data presented at the ACG Annual Scientific Meeting.“The aim of this analysis was to assess potential relationships between improvement in abdominal pain, bloating, stool consistency and global IBS symptoms in patients

    Tweet Tweets with this article
    • #ICYMI: #Bloating, #abdominal pain key in patient perception of global #IBS-#Diarrhea symptoms @SalixPharma #ACG2022 #GITwitter #Medtwitter https://t.co/jECxvaD1fk

  • Mashup Score: 0

    CHARLOTTE, N.C. — Treatment for irritable bowel syndrome with diarrhea should target bloating in addition to diarrhea and abdominal pain or discomfort, according to data presented at the ACG Annual Scientific Meeting.“The aim of this analysis was to assess potential relationships between improvement in abdominal pain, bloating, stool consistency and global IBS symptoms in patients

    Tweet Tweets with this article
    • Treatment for #IBS with #diarrhea should target #bloating in addition to diarrhea and #abdominalpain or discomfort, according to data presented at #ACG2022 @SalixPharma #GITwitter #MedTwitter https://t.co/jECxvaD1fk

  • Mashup Score: 0

    Use of an algorithm-based tool to determine the likelihood of viral etiology for acute diarrhea in children did not significantly reduce antibiotic prescriptions in developing countries, according to a study in JAMA Pediatrics.However, as the algorithm-predicted probability of viral diarrhea increased, physicians did prescribe fewer antibiotics, researchers reported in a post hoc analysis.

    Tweet Tweets with this article
    • #ICYMI from @JAMAPediatrics: Algorithm that predicts viral etiology of #diarrhea may curb inappropriate #antibioticuse #GITwitter #Medtwitter https://t.co/GtrlaiWGOI

  • Mashup Score: 2

    Use of an algorithm-based tool to determine the likelihood of viral etiology for acute diarrhea in children did not significantly reduce antibiotic prescriptions in developing countries, according to a study in JAMA Pediatrics.However, as the algorithm-predicted probability of viral diarrhea increased, physicians did prescribe fewer antibiotics, researchers reported in a post hoc analysis.

    Tweet Tweets with this article
    • Use of an algorithm-based tool to determine the likelihood of viral etiology for acute #diarrhea in #children did not significantly reduce #antibiotic #prescriptions in developing countries, according to a study in @JAMAPediatrics #GITwitter #MedTwitter https://t.co/GtrlaiWGOI

  • Mashup Score: 3

    Healio presents the following collection of FDA news related to gastroenterology, including the approval of generic diarrhea relief tablets, treatment for acid sphingomyelinase deficiency and biliary tract cancer, and more. Granules India Limited received FDA approval of its abbreviated new drug application for loperamide hydrochloride and simethicone tablets indicated for diarrhea symptom

    Tweet Tweets with this article
    • Top 7 in #FDA news: Approvals for #diarrhea relief, endoscopic devices, #Crohns treatment #GITwitter #MedTwitter https://t.co/eL0odOreWH

  • Mashup Score: 2

    Healio presents the following collection of FDA news related to gastroenterology, including the approval of generic diarrhea relief tablets, treatment for acid sphingomyelinase deficiency and biliary tract cancer, and more. Granules India Limited received FDA approval of its abbreviated new drug application for loperamide hydrochloride and simethicone tablets indicated for diarrhea symptom

    Tweet Tweets with this article
    • Top 7 in #FDA news: Approvals for #diarrhea relief, endoscopic devices, #Crohns treatment #GITwitter #MedTwitter https://t.co/eL0odOreWH

  • Mashup Score: 0

    Healio presents the following collection of FDA news related to gastroenterology, including the approval of generic diarrhea relief tablets, treatment for acid sphingomyelinase deficiency and biliary tract cancer, and more. Granules India Limited received FDA approval of its abbreviated new drug application for loperamide hydrochloride and simethicone tablets indicated for diarrhea symptom

    Tweet Tweets with this article
    • Healio presents the following collection of @US_FDA news related to #gastroenterology, including the approval of generic #diarrhea relief tablets, treatment for acid sphingomyelinase deficiency and #biliarytractcancer, and more. #GITwitter #MedTwitter https://t.co/eL0odOreWH

  • Mashup Score: 0

    Granules India Limited received FDA approval of its abbreviated new drug application for loperamide hydrochloride and simethicone tablets indicated for diarrhea symptom relief, according to a press release.The FDA determined that, among adult patients with symptoms of diarrhea, bloating, pressure and cramps, Granules India’s loperamide hydrochloride and simethicone (2 mg/125 mg) product is

    Tweet Tweets with this article
    • #ICYMI: @FDA_Drug_Info approves @GranulesIndia's generic #diarrhea relief tablets #GITwitter #MedTwitter #FDA https://t.co/y6t6Dt8PC4

  • Mashup Score: 0

    Splash pads for children at water parks offer less risk for drowning, but inadequate disinfection and poor toileting/hygiene skills create a hub for gastrointestinal illness outbreaks, noted data in Morbidity and Mortality Weekly Report.“Splash pads are popping up everywhere,” Michele C. Hlavsa, MPH, an epidemiologist and chief of the CDC Healthy Swimming Program, told Healio.

    Tweet Tweets with this article
    • #ICYMI from @CDCMMWR: ‘The #water is recycled’: Splash pads reduce child drowning risk, boost #diarrhea outbreaks #GITwitter #MedTwitter https://t.co/YOBsnFjR2B

  • Mashup Score: 1

    Granules India Limited received FDA approval of its abbreviated new drug application for loperamide hydrochloride and simethicone tablets indicated for diarrhea symptom relief, according to a press release.The FDA determined that, among adult patients with symptoms of diarrhea, bloating, pressure and cramps, Granules India’s loperamide hydrochloride and simethicone (2 mg/125 mg) product is

    Tweet Tweets with this article
    • . @GranulesIndia received @FDA_Drug_Info approval of its abbreviated new drug application for #loperamidehydrochloride and #simethiconetablets indicated for #diarrhea symptom relief #FDA #GITwitter #MedTwitter https://t.co/y6t6Dt8PC4